Aspen Grove Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
2,462
+665
| +37% | +$123K | 0.08% | 122 |
|
|
2025
Q1 | $377K | Buy |
1,797
+201
| +13% | +$42.1K | 0.07% | 138 |
|
|
2024
Q4 | $284K | Sell |
1,596
-115
| -7% | -$20.4K | 0.06% | 152 |
|
|
2024
Q3 | $338K | Sell |
1,711
-94
| -5% | -$18.6K | 0.07% | 135 |
|
|
2024
Q2 | $310K | Buy |
1,805
+75
| +4% | +$12.9K | 0.07% | 144 |
|
|
2024
Q1 | $315K | Buy |
1,730
+106
| +7% | +$19.3K | 0.09% | 139 |
|
|
2023
Q4 | $243K | Sell |
1,624
-445
| -22% | -$66.5K | 0.07% | 148 |
|
|
2023
Q3 | $308K | Buy |
2,069
+505
| +32% | +$75.3K | 0.11% | 117 |
|
|
2023
Q2 | $211K | Sell |
1,564
-226
| -13% | -$30.4K | 0.07% | 174 |
|
|
2023
Q1 | $285K | Buy |
+1,790
| New | +$285K | 0.12% | 115 |
|